vs
欧加隆（OGN）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是欧加隆的1.4倍（$2.1B vs $1.5B），Roper Technologies净利率更高（15.8% vs -13.6%，领先29.4%），Roper Technologies同比增速更快（11.3% vs -5.3%），Roper Technologies自由现金流更多（$507.0M vs $96.0M），过去两年Roper Technologies的营收复合增速更高（10.5% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
OGN vs ROP — 直观对比
营收规模更大
ROP
是对方的1.4倍
$1.5B
营收增速更快
ROP
高出16.6%
-5.3%
净利率更高
ROP
高出29.4%
-13.6%
自由现金流更多
ROP
多$411.0M
$96.0M
两年增速更快
ROP
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.1B |
| 净利润 | $-205.0M | $331.0M |
| 毛利率 | 49.2% | 69.4% |
| 营业利润率 | -9.8% | 27.2% |
| 净利率 | -13.6% | 15.8% |
| 营收同比 | -5.3% | 11.3% |
| 净利润同比 | -288.1% | 53.7% |
| 每股收益（稀释后） | $-0.78 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.6B | $2.0B | ||
| Q2 25 | $1.6B | $1.9B | ||
| Q1 25 | $1.5B | $1.9B | ||
| Q4 24 | $1.6B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B |
净利润OGNROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $-205.0M | $428.4M | ||
| Q3 25 | $160.0M | $398.5M | ||
| Q2 25 | $145.0M | $378.3M | ||
| Q1 25 | $87.0M | $331.1M | ||
| Q4 24 | $109.0M | $462.3M | ||
| Q3 24 | $359.0M | $367.9M | ||
| Q2 24 | $195.0M | $337.1M |
毛利率OGNROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 49.2% | 69.5% | ||
| Q3 25 | 53.5% | 69.5% | ||
| Q2 25 | 54.8% | 69.2% | ||
| Q1 25 | 55.6% | 68.7% | ||
| Q4 24 | 56.3% | 68.3% | ||
| Q3 24 | 58.3% | 69.2% | ||
| Q2 24 | 58.4% | 69.5% |
营业利润率OGNROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | -9.8% | 28.6% | ||
| Q3 25 | 15.2% | 28.4% | ||
| Q2 25 | 14.4% | 28.2% | ||
| Q1 25 | 6.7% | 27.9% | ||
| Q4 24 | 8.1% | 28.0% | ||
| Q3 24 | 13.1% | 28.1% | ||
| Q2 24 | 14.6% | 28.8% |
净利率OGNROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | -13.6% | 20.8% | ||
| Q3 25 | 10.0% | 19.8% | ||
| Q2 25 | 9.1% | 19.5% | ||
| Q1 25 | 5.8% | 17.6% | ||
| Q4 24 | 6.8% | 24.6% | ||
| Q3 24 | 22.7% | 20.8% | ||
| Q2 24 | 12.1% | 19.6% |
每股收益（稀释后）OGNROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-0.78 | $3.97 | ||
| Q3 25 | $0.61 | $3.68 | ||
| Q2 25 | $0.56 | $3.49 | ||
| Q1 25 | $0.33 | $3.06 | ||
| Q4 24 | $0.42 | $4.29 | ||
| Q3 24 | $1.38 | $3.40 | ||
| Q2 24 | $0.75 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $382.9M |
| 总债务越低越好 | $8.6B | $9.7B |
| 股东权益账面价值 | $752.0M | $18.8B |
| 总资产 | $12.9B | $34.6B |
| 负债/权益比越低杠杆越低 | 11.49× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资OGNROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $574.0M | $297.4M | ||
| Q3 25 | $672.0M | $320.0M | ||
| Q2 25 | $599.0M | $242.4M | ||
| Q1 25 | $547.0M | $372.8M | ||
| Q4 24 | $675.0M | $188.2M | ||
| Q3 24 | $763.0M | $269.6M | ||
| Q2 24 | $704.0M | $251.5M |
总债务OGNROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $8.6B | $9.3B | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | $7.6B | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — |
股东权益OGNROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $752.0M | $19.9B | ||
| Q3 25 | $906.0M | $20.0B | ||
| Q2 25 | $733.0M | $19.6B | ||
| Q1 25 | $542.0M | $19.2B | ||
| Q4 24 | $472.0M | $18.9B | ||
| Q3 24 | $493.0M | $18.5B | ||
| Q2 24 | $144.0M | $18.1B |
总资产OGNROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $12.9B | $34.6B | ||
| Q3 25 | $13.6B | $34.6B | ||
| Q2 25 | $13.5B | $33.2B | ||
| Q1 25 | $13.2B | $31.4B | ||
| Q4 24 | $13.1B | $31.3B | ||
| Q3 24 | $12.8B | $31.6B | ||
| Q2 24 | $12.2B | $29.8B |
负债/权益比OGNROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 11.49× | 0.47× | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | 0.40× | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | — |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $507.0M |
| 自由现金流率自由现金流/营收 | 6.4% | 24.2% |
| 资本支出强度资本支出/营收 | 3.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $538.0M | — |
8季度趋势，按日历期对齐
经营现金流OGNROP
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $738.0M | ||
| Q3 25 | $264.0M | $869.5M | ||
| Q2 25 | $220.0M | $404.1M | ||
| Q1 25 | $75.0M | $528.7M | ||
| Q4 24 | $390.0M | $722.2M | ||
| Q3 24 | $141.0M | $755.4M | ||
| Q2 24 | $332.0M | $384.1M |
自由现金流OGNROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — |
自由现金流率OGNROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — |
资本支出强度OGNROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — |
现金转化率OGNROP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | 1.65× | 2.18× | ||
| Q2 25 | 1.52× | 1.07× | ||
| Q1 25 | 0.86× | 1.60× | ||
| Q4 24 | 3.58× | 1.56× | ||
| Q3 24 | 0.39× | 2.05× | ||
| Q2 24 | 1.70× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
